AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Resilience of Weight Loss Drugs Amid Health Initiatives
This chapter explores how potential political changes could affect the pharmaceutical industry, especially in relation to Eli Lilly's GLP weight loss drugs. It highlights the ongoing necessity and benefits of these medications for managing obesity and associated health conditions, despite new health initiatives.